Found 6 results
Author Keyword [ Title(Desc)] Type Year
Filters: Author is Pearce, Martin C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Pearce MC, Satterthwait AC, Zhang X-K, Kolluri SKumar.  2019.  Cancer therapeutics based on BCL-2 functional conversion.. Apoptosis. 24(1-2):1-2.
D
Song Z, Pearce MC, Jiang Y, Yang L, Goodall C, Miranda CL, Milovancev M, Bracha S, Kolluri SK, Maier CS.  2020.  Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities.. Sci Rep. 10(1):727.
Song Z, Pearce MC, Jiang Y, Yang L, Goodall C, Miranda CL, Milovancev M, Bracha S, Kolluri SK, Maier CS.  2020.  Delineation of hypoxia-induced proteome shifts in osteosarcoma cells with different metastatic propensities.. Sci Rep. 10(1):727.
I
Kopparapu PR, Pearce MC, Löhr CV, Duong C, Jang HSang, Tyavanagimatt S, O'Donnell EF, Nakshatri H, Kolluri SK.  2024.  Identification and Characterization of a Small Molecule Bcl-2 Functional Converter.. Cancer Res Commun. 4(3):634-644.
Morgan E, Gamble JT, Pearce MC, Elson DJ, Tanguay RL, Kolluri SKumar, Reich NO.  2019.  Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell delivery.. Apoptosis.
Pearce MC, Gamble JT, Kopparapu PR, O'Donnell EF, Mueller MJ, Jang HSang, Greenwood JA, Satterthwait AC, Tanguay RL, Zhang X-K et al..  2018.  Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells.. Oncotarget. 9(40):26072-26085.